Inovio Pharmaceuticals Inc (NASDAQ:INO)

8.39
Delayed Data
As of May 27
 +0.03 / +0.36%
Today’s Change
6.33
Today|||52-Week Range
14.20
-8.61%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues9.8M4.1M13.5M10.5M
 
 
 
 
 
Depreciation And Amortization2.0M2.0M2.1M1.6M
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses30.0M26.8M32.9M48.4M
 
 
 
 
 
Research And Development20.0M18.0M21.4M34.1M
 
 
 
 
 
Total Operating Expenses32.0M28.8M35.0M50.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-22.2M-24.6M-21.5M-39.5M
 
 
 
 
 
Extraordinary Credit8.7M2.0M--3.0M
 
 
 
 
Extraordinary Charge0.000.00-46.7M--
 
 
Pre-Tax Equity Earnings-2.4M1.6M----
 
 
 
Other Expenses587.0K1.2M2.0M331.5K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-15.3M-19.7M-66.1M-36.1M
 
 
 
 
 
Minority Interest-51.2K-44.0K-55.1K-18.4K
 
 
 
 
 
Net Income-15.3M-19.7M-66.0M-36.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS31.6M34.1M46.1M59.1M
 
 
 
 
 
Shares To Calculate EPS Diluted31.6M34.1M46.1M59.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.48-$0.56-$1.44-$0.64
 
 
 
 
 
EPS Diluted-$0.48-$0.56-$1.44-$0.64
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account